Available to sourceHuman Prescription DrugGastrointestinal

POTASSIUM PHOSPHATES

Active ingredients · Dibasic Potassium Phosphate, Monobasic Potassium Phosphate

236 mg/mL / 224 mg/mL · Injection Solution Concentrate

By GLENMARK PHARMACEUTICALS INC., USA

NDC: 68462-786
Route: Intravenous
Therapeutic class: Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative , Osmotic Laxative , Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt , Potassium Salt
Marketing category: ANDA

Package sizes

25 VIAL, SINGLE-DOSE in 1 CARTON (68462-786-25) / 5 mL in 1 VIAL, SINGLE-DOSE (68462-786-05)NDC 68462-786-25Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.